Per una migliore esperienza, mantieni il tuo browser aggiornato. Controlla qui le ultime versioni.

January 2025

Axxam Appoints Ciriaco Maraschiello as Chief Executive Officer 

Axxam, a leading innovation partner for life sciences research based in OpenZone, is pleased to announce that its Board of Directors has appointed Dr. Ciriaco Maraschiello, who previously served as Chief Operating Officer (COO), as Chief Executive Officer (CEO), effective January 1, 2025. Dr. Ciriaco Maraschiello succeeds Dr. Stefan Lohmer, Axxam’s Co-Founder and CEO for the past 25 years. Dr. Lohmer will transition to the role of Board Member and Chairman of the Scientific Advisory Board, continuing to contribute his extensive expertise and visionary leadership to the company’s strategic direction.
Dr. Maraschiello brings over 25 years of experience in the Life Sciences Contract Research Service sector, with a strong operational management background, a proven track record of business transformation, and a specific expertise in preclinical and pharmaceutical development. Prior to joining Axxam in July 2023, he held leadership roles at Harlan Laboratories, Aptuit Inc. and Evotec SE, where he successfully developed and led R&D operations.
Dr. Ciriaco Maraschiello
Newly appointed Chief Executive Officer of Axxam 

I am honored and excited to be taking on the role of CEO. The company’s outstanding legacy of innovation and excellence in life sciences research is a testament to the vision of Stefan and the remarkable Axxam team. I look forward to building on this strong foundation and working closely with our talented team, partners, and clients to drive impactful solutions that address the challenges of today and tomorrow.

Dr. Lohmer
Co-founder of Axxam

It has been an absolute privilege and a dream fulfilled to lead Axxam and work alongside so many talented and outstanding individuals over the past 25 years. The vision for Axxam remains consistent with its founding principles, but the company has reached a point in its journey where it is necessary to implement the next leadership generation who can further evolve our strategy and take the company to new heights. I am happy to support Ciriaco in his new role as CEO and confident he will deliver continued success. I am pleased to be staying very close to Axxam in the future through my role as Board Member and Chairman of the Scientific Advisory Board. I look forward to continuing to contribute to Axxam’s scientific excellence and evolution.

Act 

News 
Scopri la sezione News per restare sempre aggiornato su ciò che riguarda gli zoner e sui temi pià rilevanti legati all'innovazione e alle Scienze della Vita.
tutte le news